CINECA IRIS Institutional Research Information System

RUSSO, Isabella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.331
EU - Europa 1.550
AS - Asia 724
AF - Africa 26
OC - Oceania 7
SA - Sud America 4
Totale 4.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.309
CN - Cina 529
IT - Italia 322
IE - Irlanda 284
SE - Svezia 182
UA - Ucraina 155
FI - Finlandia 153
FR - Francia 134
DE - Germania 125
KR - Corea 100
GB - Regno Unito 61
AT - Austria 57
VN - Vietnam 45
PL - Polonia 38
SN - Senegal 21
CA - Canada 18
BE - Belgio 14
GR - Grecia 13
IN - India 10
HK - Hong Kong 9
SG - Singapore 8
JP - Giappone 7
AU - Australia 6
IR - Iran 5
TW - Taiwan 5
MX - Messico 4
BR - Brasile 3
DK - Danimarca 3
ES - Italia 2
ID - Indonesia 2
NL - Olanda 2
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
KE - Kenya 1
KW - Kuwait 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
SI - Slovenia 1
TN - Tunisia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 4.642
Salva come PNG Salva come JPEG
Città #
Beijing 372
Chandler 324
Dublin 284
Torino 193
Houston 167
Jacksonville 136
Ann Arbor 115
Fairfield 115
Wilmington 109
Medford 108
Villeurbanne 108
Nyköping 95
Princeton 92
Ashburn 80
Dearborn 70
Vienna 56
Fremont 53
Seattle 45
Woodbridge 44
Cambridge 41
Warsaw 34
New York 30
Dong Ket 29
Boston 26
Milan 22
Pisa 19
Hefei 16
Nanjing 15
Turin 15
Brussels 14
Redwood City 14
Boardman 13
Falls Church 12
Kunming 11
Athens 10
Norwalk 10
Shanghai 10
Detroit 9
Guangzhou 9
Xian 9
Lachine 8
San Diego 8
San Mateo 8
Verona 8
Nanchang 7
Toronto 7
Hebei 6
Pune 6
Chengdu 5
Napoli 5
Philadelphia 5
Seoul 5
Taipei 5
Upper Marlboro 5
Chongqing 4
Hangzhou 4
Jinan 4
Silver Spring 4
Wuhan 4
Zhengzhou 4
Central District 3
Düsseldorf 3
Hong Kong 3
Nashville 3
Palermo 3
Redmond 3
Shenyang 3
Bellinzago Novarese 2
Changsha 2
Copenhagen 2
Courtenay 2
Fuzhou 2
Genova 2
Kharkiv 2
Leawood 2
Mahwah 2
Monmouth Junction 2
Mountain View 2
Phoenix 2
Romainville 2
Rome 2
Shaoxing 2
Southend 2
Swansea 2
Tabriz 2
Trieste 2
Vestignè 2
Washington 2
Wenzhou 2
Ürümqi 2
Absecon 1
Adelaide 1
Adnan Menderes 1
Alessandria 1
Ardabil 1
Auburn Hills 1
Auckland 1
Ballabio 1
Baotou 1
Bari 1
Totale 3.123
Salva come PNG Salva come JPEG
Nome #
Platelets, diabetes and myocardial ischemia/reperfusion injury 185
High glucose reduces the anti-aggregating effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 118
A short-term incubation with high glucose impairs VASP phosphorylation at serine 239 in response to the nitric oxide/cGMP pathway in vascular smooth muscle cells: role of oxidative stress. 103
Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation 103
The Cardiovascular Effects of Metformin: Further Reasons to Consider an Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus 99
Association between high on-aspirin platelet reactivity and reduced superoxide dismutase activity in patients affected by type 2 diabetes mellitus or primary hypercholesterolemia 99
Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia 90
Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein 82
Effects of PCSK9 inhibitors on platelet function in adults with hypercholesterolemia 81
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades 81
Cardioprotective properties of human platelets are lost in uncontrolled diabetes mellitus: A study in isolated rat hearts 79
High glucose reduces the anti-aggreganting effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 76
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance 75
Influence of Cardiometabolic Risk Factors on Platelet Function 75
Relevance of the vascular effects of insulin in the rationale of its therapeutical use 74
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin 73
Contribution of insulin resistance to vascular dysfunction 72
GLP-1 reduces the activation of PI3K and MAPK pathways and of oxidative stress induced by Na-arachidonate in platelets. 71
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets. 70
Effects of high glucose on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells from obese and lean zucker rats. 68
Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling 68
Aspirin resistant subjects present a proinflammatory milieu with an increased oxidative stress: in these conditions, high glucose fails to influence platelet responses to agonists. 67
Glucagon-Like Peptide 1 reduces platelet activation: effects on PI-3K and MAPK pathways and oxidative stress in the presence of arachidonic acid. 67
Platelets Protect Against Myocardial Injury, but Platelets From Patients With Type 2 Diabetes Mellitus (T2DM) Lose their Protective Properties 65
Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy 65
Hypercholesterolemia impairs the Glucagon-like peptide 1 action on platelets: Effects of a lipid-lowering treatment with simvastatin 63
Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. 62
Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome 61
A novel truncated form of eNOS associates with altered vascular function. 61
C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells 60
Thrombopoietin contributes to enhanced platelet activation in patients with type 1 diabetes mellitus 59
Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation. 58
Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase. 57
Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress. 56
Postprandial dysmetabolism and oxidative stress in type 2 diabetes: pathogenetic mechanisms and therapeutic strategies. 56
Role of NMDA receptor in homocysteine-induced activation of Mitogen-Activated Protein Kinase and Phosphatidyl Inositol 3-Kinase pathways in cultured human vascular smooth muscle cells 55
Il miglioramento del controllo glicemico riduce la resistenza piastrinica all'aspirina nei pazienti affetti da diabete di tipo 2 55
Impairment of GLP-1 effects in platelets from subjects affected by type 2 diabetes mellitus 54
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus 54
Resistenza agli effetti del GLP-1 sulla risposta pastrinica nel diabete di tipo 2 53
Transferrin Saturation Inversely Correlates with Platelet Function 53
Glucagon-Like Peptide 1 reduces platelet activation induced by sodium arachidonate through the inhibition of PI-3K and MAPK pathways. 52
L'acido oleico incrementa trascrizione, sintesi e secrezione del VEGF in cellule muscolari lisce vascolari aortiche: ridotto effetto in condizioni di insulino-resistenza 52
PCSK9 Biology and Its Role in Atherothrombosis 51
Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway. 50
GLP-1 influences the inhibitory effects of nitric oxide on platelets. 50
Transferrin Saturation and Its Association with Platelet Reactivity 50
N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. 49
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. 49
Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets. 48
Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity. 48
Leptin and vascular smooth muscle cells. 48
A short-term improvement of blood glucose control increases aspirin sensitivity in aspirin-resistant type 2 diabetic men. 48
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus. 48
Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells 47
In type 2 diabetes mellitus the GLP-1 effects on platelets are impaired. 47
Influence of oleic acid on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells: signalling molecules involved and role of insulin resistance 46
Comparison between the effects of the rapid recombinant insulin analog LYSPRO (Lys B28, Pro B29) and those of human regular insulin on platelet cyclic nucleotides and aggregation 45
Acido oleico e regolazione del VEGF in cellule muscolari lisce vascolari aortiche in condizioni di insulino-sensibilità e insulino-resistenza. 45
GLP-1 and liraglutide increase the platelet inhibitory effects of nitric oxide. 45
Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects. 43
An intensive control of blood glucose improves platelet sensitivity to aspirin in type 2 diabetes mellitus. 43
Il GLP-1 aumenta l'effetto inibitorio dell'ossido nitrico sulle piastrine con meccanismo GLP-1R indipendente. 43
Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content. 42
Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. 41
Platelets poorly controlled type 2 diabetes subjects show an impaired ability to protect against the cardiac ischaemia/reperfusion injury 41
High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism 39
Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: A 12-month follow-up 39
The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents 38
Insulin stimulates the polymorphonuclear leukocyte chemokinesis. 37
Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways 37
Platelet dysfunction in central obesity 36
Influenza dell’alto glucosio sull’aggregazione piastrinica in soggetti aspirino-trattati. 36
Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress 36
Insulin, at physiological concentrations, enhances the polymorphonuclear leukocyte chemotactic properties. 35
Nonenzymatic glycation of fibronectin impairs adhesive and proliferative properties of human vascular smooth muscle cells. 32
Sodium azide in commercially available C-reactive protein preparations does not influence matrix metalloproteinase-2 synthesis and release in cultured human aortic vascular smooth muscle cells 32
Platelet resistance to the anti-aggregating agents in the insulin resistant states. 31
Influence of protamine on adhesion, chemotaxis and proliferation of human vascular smooth muscle cells. 31
Non-HDL cholesterol is a determinant of aspirin-resistance in type 2 diabetes mellitus. 31
L-arginine modulates aggregation and intracellular cyclic 3',5'-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative agent. 30
The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance. 30
Prothrombotic phenotype in covid-19: Focus on platelets 30
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways 27
Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity 24
Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis 19
Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell 19
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis 16
Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis 9
Platelets and Cardioprotection: The Role of Nitric Oxide and Carbon Oxide 3
Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis 2
Impact of Physical Exercise on Platelets: Focus on Its Effects in Metabolic Chronic Diseases 1
Aberrant Platelet Aggregation as Initial Presentation of Essential Thrombocythemia: Failure of Entero-Coated Aspirin to Reduce Platelet Hyperactivation 1
Totale 4.895
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.734
article - articoli 0
book - libri 0
conference - conferenze 4.184
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019135 0 0 0 0 0 0 0 0 0 34 67 34
2019/2020745 32 8 39 78 47 174 96 46 90 60 41 34
2020/2021578 62 47 57 25 43 41 33 17 97 54 32 70
2021/2022680 50 16 14 42 23 23 27 37 17 55 193 183
2022/20231.015 116 71 34 64 104 308 103 50 93 22 36 14
2023/2024324 42 98 22 28 28 65 10 12 0 19 0 0
Totale 4.895